| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458866 | Radiotherapy and Oncology | 2018 | 7 Pages |
Abstract
The combination of EBRT and HDR-BT with adequate dose constraints to risk organs provides satisfactory long-term tumour control even in high-risk patients. GI toxicity stabilised but GU toxicity progressed during the 10-year follow up.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lennart Ã
ström, Erik Grusell, Fredrik Sandin, Ingela Turesson, Lars Holmberg,